Biography of Advisory Board

Ex Deputy Foreign Minister of Armenia (1997-2000 and 2004-2008)

Ex-Ambassador in India, Nepal, Sri Lanka, and Indonesia (2000-2004)

Senior Advisor to the United Nations

 Professor of Practice of Political Science at the University of Massachusetts Amherst

Prof Baibourtian has also been a Senior Adviser to the United Nations Resident Coordinat

Ex Deputy Foreign Minister of Armenia (1997-2000 and 2004-2008)

Ex-Ambassador in India, Nepal, Sri Lanka, and Indonesia (2000-2004)

Senior Advisor to the United Nations

 Professor of Practice of Political Science at the University of Massachusetts Amherst

Prof Baibourtian has also been a Senior Adviser to the United Nations Resident Coordinator and UNDP Resident Representative in Armenia (2008-2013). In this capacity, he coordinated the activities of twelve UN agencies on the country scale. Along with the U.S. Deputy Assistant Secretary, Prof Baibourtian co-chaired the U.S.-Armenia Security Dialogue. He also co-chaired bilateral Intergovernmental Commissions on Trade, Economic, Technological, Cultural, and Educational Cooperation with India and China. He was the Deputy Permanent Representative to the UN in New York (1993-1995) dealing with international peace and security issues at the UN Headquarters and then served as the Consul General in Los Angeles (1995-1997). Prof Baibourtian has been a Professor of Practice of Political Science at the University of Massachusetts Amherst and is a Consultant to various agencies in international affairs, diplomacy, and international development.

Prof Baibourtian holds two PhDs – in International Studies and Modern World History and is the recipient of several awards, including the Fridtjof Nansen Humanitarian Service Medal.

Director of Head and Neck Cancer Research Division in Johns Hopkins School of Medicine’s Department of Otolaryngology

Professor of Oncology, Cellular & Molecular Medicine, Urology, Genetics, and Pathology at Johns Hopkins Medical School

Authored over 550 peer-reviewed publications, contributed 45 cancer reviews and chapters, and invented 28

Director of Head and Neck Cancer Research Division in Johns Hopkins School of Medicine’s Department of Otolaryngology

Professor of Oncology, Cellular & Molecular Medicine, Urology, Genetics, and Pathology at Johns Hopkins Medical School

Authored over 550 peer-reviewed publications, contributed 45 cancer reviews and chapters, and invented 28 biotechnology patents

One of the world’s most highly cited researchers in clinical and medical journals.

Known for in research in biomarkers for early detection and therapy and profiled by TIME magazine in 2001 as one of America’s best in science and medicine, Dr. Sidransky is a leading expert in oncology and precision medicine widely respected in the biopharmaceutical industry. Dr. Sidransky is currently the Director of the Head and Neck Cancer Research Division at Johns Hopkins University School of Medicine’s Department of Otolaryngology; and Professor of Oncology, Cellular & Molecular Medicine, Urology, Genetics, and Pathology at the Johns Hopkins University School of Medicine. Dr. Sidransky is also serving as a member on the Scientific Advisory Boards of numerous professional organizations and institutions, including the American Association for Cancer Research (AACR), the American Society of Clinical Oncology (ASCO), and the National Cancer Institute (NCI) of the U.S. Having authored over 550 peer-reviewed publications, contributed 45 cancer reviews and chapters, and invented 28 biotechnology patents, Dr. Sidransky is one of the world’s most highly cited researchers in clinical and medical journals.

Dr. Sidransky has accumulated immense industry experience and exceptional expertise, not only in scientific research, but also in business operations, corporate governance and investment strategies. Dr. Sidransky is a founder of a number of biotechnology companies such as Champions Oncology (Nasdaq; CSBR). Previously, Dr. Sidransky was Vice Chairman of ImClone Systems Inc., a global biopharmaceutical company committed to advancing oncology care, until its acquisition by Eli Lilly. Dr. Sidransky is also a Co-Founder and Managing Partner of the Israel Biotech Fund. Furthermore, Dr. Sidransky is a highly-experienced board member, after having served as a director on the boards of Galmed Pharmaceuticals (Nasdaq: GLMD), Orgenesis (Nasdaq: ORGS), Advaxis (Nasdaq: ADXS), and Ayala (Nasdaq: AYLA).

CEO, PlanetERP

Senior Consultant in SAP Finance & Controlling 

Mr. Subbarao V. Seethamsetty is an Engineer and Technologist with over three decades of corporate experience in North America. He heads PlanetERP Inc. based in Collins, NY providing “Large Systems” design and implementation services in Financial, Industrial, Logistics, and Agric

CEO, PlanetERP

Senior Consultant in SAP Finance & Controlling 

Mr. Subbarao V. Seethamsetty is an Engineer and Technologist with over three decades of corporate experience in North America. He heads PlanetERP Inc. based in Collins, NY providing “Large Systems” design and implementation services in Financial, Industrial, Logistics, and Agriculture spaces. A compelling life-long draw for him has always been to leverage his Systems-design skills to benefit huge swaths of humanity struggling in “extreme poverty” globally as defined by the UN as those families with income of less than $2 a day.

Mr. Subbarao currently works as a consultant in  Senior SAP Finance & Controlling FICO SME with 19+ years experience in ERP transformative engagements for large multi-nationals with a global foot print. As a result, he has gained deep skills like Expert-level in CO - Controlling, Product costing for both repetitive, discrete and make-to-order scenarios with PS project systems and Revenue Recognition.
 

Global Head, Corporate Strategy and Corporate Communications, Ascentage Pharmaceuticals 

Dr Pathak is an Oncologist, biotechnologist, and senior business executive currently working as the Global Head of Corporate Strategy, Corporate Communications, and Medical Affairs of a Multinational Biotechnology company with operations in US, China, 

Global Head, Corporate Strategy and Corporate Communications, Ascentage Pharmaceuticals 

Dr Pathak is an Oncologist, biotechnologist, and senior business executive currently working as the Global Head of Corporate Strategy, Corporate Communications, and Medical Affairs of a Multinational Biotechnology company with operations in US, China, EU, and Australia in the fields of cancers, hepatitis B, and age related diseases. He has been involved in all phases of drug development including preclinical/ clinical and commercialization activities. Dr Pathak has led the US and Global launch of 9 novel cancer drugs and biosimilars for the management of Acute and Chronic Leukemias, Lymphomas, solid tumors, and chemotherapy induced neutropenia.  

Dr. Pathak completed his medical residency and PhD in Oncology at All India Institute of Medical Sciences (AIIMS), New Delhi; Fellowship in Oncology from MD Anderson Cancer Center, Houston: and MBA from Columbia University, NY.  He has published extensively in high impact international journals on Fundamental, Translational, Clinical, as well as Health Economics and Outcome research. He received Gold Medal in Oncology at AIIMS and multiple international awards for his research including International Development and Education Award from American Society for Clinical Oncology 2006, and Outstanding Clinical Scholar Award from American Association for Cancer Research 2007. He was elected to the Fellowship of the Royal College of Physicians (FRCP), UK in 2015 honoring his overall contributions to health care.